(Q57658462)

1

0 references

B Perret

2

0 references

D Arveiler

4

0 references

J Yarnell

5

0 references

P Ducimetière

6

0 references

J Ferrières

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

7

0 references

publication date

November 2006

0 references

published in

Diabetes and Metabolism

0 references

volume

32

0 references

issue

5

0 references

page(s)

475-479

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021

The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970306-3

7 January 2021